ALPK1抑制URAT1与尿酸稳态相关
该研究旨在识别调控尿酸转运体1(URAT1)的蛋白。在492例汉族病例对照样本中,ALPK1 rs11726117(M861T; T)通过SLC22A12基因SNP降低痛风风险(OR 0.39, 95%CI 0.23,0.67)。在hALPK1转基因小鼠中过表达ALPK1可降低URAT1蛋白水平(P=0.0045),提示ALPK1是URAT1的潜在抑制因子。
要点
- ALPK1 rs11726117 T等位基因通过SLC22A12 SNP降低痛风风险(OR 0.39)。
- ALPK1过表达小鼠肾脏URAT1蛋白水平降低(P=0.0045)。
- MSU晶体通过上调ALPK1抑制人肾-2细胞中URAT1表达。
核心结论
- ALPK1表达升高可降低URAT1表达,ALPK1可能是URAT1蛋白表达的潜在抑制因子。
- ALPK1可能通过SLC22A12防止尿酸重吸收,并与痛风负相关。
研究设计与样本
- 临床数据集为492例汉族病例对照样本(104例痛风,388例对照)。
- 对ALPK1和SLC22A12三个与高痛风风险及尿酸水平相关的基因座进行基因分型。
- 在hALPK1转基因小鼠体内评估ALPK1过表达对URAT1蛋白表达的影响。
- 在ALPK1小干扰RNA转染的人肾-2细胞中,用MSU晶体刺激后检测ALPK1和URAT1蛋白水平。
主要发现
- ALPK1 rs11726117(M861T; T)通过SLC22A12基因SNP rs3825016和rs475688降低痛风风险,与ALPK1 rs11726117(C)等位基因受试者相比,rs11726117(CT+TT)vs rs3825016的OR为0.39(95%CI 0.23,0.67)。
- rs11726117(CT+TT)vs rs475688的OR为0.39(95%CI 0.23,0.67)。
- ALPK1过表达小鼠显示URAT1蛋白水平较低(P=0.0045)。
- 在小鼠肾脏近端小管细胞中检测到内源性ALPK1蛋白。
- MSU晶体通过上调ALPK1抑制人肾-2细胞中URAT1表达。
临床怎么用
- ALPK1可能作为痛风风险分层或尿酸稳态评估的潜在生物标志物。
- 靶向ALPK1-URAT1轴可能为痛风或高尿酸血症提供新的治疗思路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to identify a protein for urate transporter 1 (URAT1) regulation. METHODS: The clinical dataset consisted of 492 case-control samples of Han Chinese (104 gout and 388 controls). Three alpha kinase 1 ( ALPK1 ) and SLC22A12 loci associated with high gout risk and uric acid levels were genotyped. The overexpression of ALPK1 on URAT1 protein expression was evaluated in vivo in h ALPK1 transgenic mice. The in vitro protein levels of ALPK1 and URAT1 in ALPK1 small interfering RNA-transfected human kidney-2 cells with MSU crystal stimulation were examined. RESULTS: ALPK1 , which is a single nucleotide polymorphism (SNP) of rs11726117 (M861T; T), reduced the risk of gout via the SLC22A12 gene SNPs rs3825016 and rs475688, as compared with the subject of ALPK1 rs11726117 (C) allele {rs11726117 [CT + TT] vs rs3825016, odds ratio [OR] 0.39 [95% confidence interval (CI) 0.23, 0.67]; rs11726117 [CT + TT] vs rs475688, OR 0.39 [95% CI 0.23, 0.67]}. ALPK1-overexpressed mice demonstrated lower levels of URAT1 protein ( P = 0.0045). Mouse endogenous ALPK1 proteins were detected in renal proximal tubule cells. MSU crystals inhibited URAT1 expressions through an upregulation of ALPK1 in human kidney-2 cells. CONCLUSION: Elevated ALPK1 expression decreased URAT1 expression. ALPK1 might prevent the impact of urate reuptake via SLC22A12 and appeared to be negatively associated with gout. ALPK1 is a potential repressor of URAT1 protein expression.
引用
- Kuo TM, Huang CM, Tu HP, et al. URAT1 inhibition by ALPK1 is associated with uric acid homeostasis. Rheumatology (Oxford). 2017. PMID: 28039413. doi:10.1093/rheumatology/kew463
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。